Literature DB >> 19955181

Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways.

Shunsuke Suzuki1, Yue Zhou, Alaa Refaat, Ichiro Takasaki, Keiichi Koizumi, Shoji Yamaoka, Yoshiaki Tabuchi, Ikuo Saiki, Hiroaki Sakurai.   

Abstract

We previously reported that human T cell lymphotropic virus 1 (HTLV-1) Tax oncoprotein constitutively activates transforming growth factor-beta-activated kinase 1 (TAK1). Here, we established Tax-positive HuT-102 cells stably transfected with a short hairpin RNA vector (HuT-shTAK1 cells) and investigated the physiological function of TAK1. Microarray analysis demonstrated that several interferon (IFN)-inducible genes, including chemokines such as CXCL10 and CCL5, were significantly down-regulated in HuT-shTAK1 cells. In contrast, Tax-mediated constitutive activation of nuclear factor-kappaB (NF-kappaB) was intact in HuT-shTAK1 cells. IFN-regulatory factor 3 (IRF3), a critical transcription factor in innate immunity to viral infection, was constitutively activated in a Tax-dependent manner. Activation of IRF3 and IRF3-dependent gene expressions was dependent on TAK1 and TANK-binding kinase 1 (TBK1). On the other hand, IRF4, another member in the IRF family of transcription factors overexpressed in a Tax-independent manner, negatively regulated TAK1-dependent IRF3 transcriptional activity. Together, HTLV-1 manipulates IFN signaling by regulating both positive and negative IRFs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955181      PMCID: PMC2836049          DOI: 10.1074/jbc.M109.031476

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

Review 2.  Structural mechanism of RNA recognition by the RIG-I-like receptors.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

3.  TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.

Authors:  Ryoko Yoshida; Giichi Takaesu; Hideyuki Yoshida; Fuyuki Okamoto; Tomoko Yoshioka; Yongwon Choi; Shizuo Akira; Taro Kawai; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

Review 4.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.

Authors:  Masao Matsuoka; Kuan-Teh Jeang
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

5.  Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes.

Authors:  S Sharma; Y Mamane; N Grandvaux; J Bartlett; L Petropoulos; R Lin; J Hiscott
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-01       Impact factor: 2.205

6.  Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300.

Authors:  Jing Zhang; Osamu Yamada; Kenji Kawagishi; Hiromasa Araki; Shoji Yamaoka; Toshio Hattori; Kunitada Shimotohno
Journal:  Virology       Date:  2008-08-03       Impact factor: 3.616

7.  Retroviral oncoprotein Tax deregulates NF-kappaB by activating Tak1 and mediating the physical association of Tak1-IKK.

Authors:  Xuefeng Wu; Shao-Cong Sun
Journal:  EMBO Rep       Date:  2007-03-16       Impact factor: 8.807

8.  Identification of genetic networks involved in the cell growth arrest and differentiation of a rat astrocyte cell line RCG-12.

Authors:  Ichiro Takasaki; Satoko Takarada; Mamoru Fukuchi; Makoto Yasuda; Masaaki Tsuda; Yoshiaki Tabuchi
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

9.  Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB.

Authors:  Shunsuke Suzuki; Pattama Singhirunnusorn; Akinori Mori; Shoji Yamaoka; Isao Kitajima; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2007-07-11       Impact factor: 5.157

10.  The TAK1-JNK cascade is required for IRF3 function in the innate immune response.

Authors:  Bianhong Zhang; Meng Li; Liang Chen; Kai Yang; Yufei Shan; Lianhui Zhu; Shaogang Sun; Lin Li; Chen Wang
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

View more
  16 in total

1.  Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.

Authors:  Alaa Refaat; Yue Zhou; Shunsuke Suzuki; Ichiro Takasaki; Keiichi Koizumi; Shoji Yamaoka; Yoshiaki Tabuchi; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

2.  Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line.

Authors:  Morgan E Meissner; Luiza M Mendonça; Wei Zhang; Louis M Mansky
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.

Authors:  Ling Wang; Ngoc L Toomey; Luis A Diaz; Gail Walker; Juan C Ramos; Glen N Barber; Shunbin Ning
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.

Authors:  Saifur Rahman; Zafar K Khan; Brian Wigdahl; Stephen R Jennings; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

5.  Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.

Authors:  Chun-Kit Yuen; Ching-Ping Chan; Sin-Yee Fung; Pei-Hui Wang; Wan-Man Wong; Hei-Man Vincent Tang; Kit-San Yuen; Chi-Ping Chan; Dong-Yan Jin; Kin-Hang Kok
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

6.  Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.

Authors:  Manraj Singh Narulla; Ahlam Alsairi; Lucie Charmier; Stephen Noonan; David Conroy; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 7.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

Review 8.  Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.

Authors:  Zhaoxia Qu; Gutian Xiao
Journal:  Viruses       Date:  2011-06       Impact factor: 5.048

9.  A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.

Authors:  Herwig P Moll; Andy Lee; Darlan C Minussi; Cleide G da Silva; Eva Csizmadia; Manoj Bhasin; Christiane Ferran
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

10.  Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.

Authors:  Shuichi Kinpara; Mami Kijiyama; Ayako Takamori; Atsuhiko Hasegawa; Amane Sasada; Takao Masuda; Yuetsu Tanaka; Atae Utsunomiya; Mari Kannagi
Journal:  Retrovirology       Date:  2013-05-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.